<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00842803</url>
  </required_header>
  <id_info>
    <org_study_id>SDR-08-030</org_study_id>
    <nct_id>NCT00842803</nct_id>
  </id_info>
  <brief_title>Post-Operative Use of Salt Poor Albumin Solution in Resuscitation of Orthotopic Liver Transplant</brief_title>
  <official_title>Post-Operative Use of Salt Poor Albumin Solution in Resuscitation of Orthotopic Liver Transplant Recipients Status 1-2. A Prospective Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McGill University Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McGill University Health Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to examine if outcome after liver transplantation is improved by
      using albumin infusion post-transplantation.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post Transplant Liver Function Test (PTLFT)</measure>
    <time_frame>Post-operative Day1 through 7 and Day 15,30, 45</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional 6 minutes walking test</measure>
    <time_frame>Post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calculated creatinine clearance</measure>
    <time_frame>Post-operative day 1, 7, 15, 30, 45</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of mechanical ventilation</measure>
    <time_frame>post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of renal replacement therapy</measure>
    <time_frame>postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU readmission rate</measure>
    <time_frame>post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>reintubation rate</measure>
    <time_frame>post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative infection rate</measure>
    <time_frame>Post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need to re-operation unrelated to technical complication</measure>
    <time_frame>post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional hand grip Jamar Dynamometer hand grip test</measure>
    <time_frame>Post-op day 7, 15, 30</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Liver Transplantation</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in this group will not be allowed albumin or any other colloids fluid for the first 7 days post-operative</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Albumin group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will receive albumin infusions 3 times a day for the first 7 days post-operative</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Albumin infusion (25% albumin)</intervention_name>
    <description>Patients in this arm will receive albumin infusions 3 times a day for the first 7 days post-operative</description>
    <arm_group_label>Albumin group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or older

          -  Canadian Transplant status 1 or 2

          -  Patients at the Royal Victoria Hospital, Montreal, Canada

        Exclusion Criteria:

          -  Emergency liver transplant (canadian transplant status 3 or 4)

          -  patients who have received more than 300cc of albumin within 48 hours prior to
             transplant

          -  patients who underwent previous solid organ transplant

          -  multi-organs transplant recipients

          -  patients who had previous adverse reaction to human albumin solution

          -  patients who have religious restriction to receiving human blood products.

          -  patients or surrogate unable to give consent to the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mathieu Rousseau, MD</last_name>
    <phone>514.567.0292</phone>
    <email>mathieu.rousseau@mail.mcgill.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mazen Hassanain, MD</last_name>
    <phone>514.934.1934</phone>
    <phone_ext>31600</phone_ext>
    <email>mazen.hassanain@muhc.mcgill.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Royal Victoria Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2009</study_first_submitted>
  <study_first_submitted_qc>February 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2009</study_first_posted>
  <last_update_submitted>September 17, 2009</last_update_submitted>
  <last_update_submitted_qc>September 17, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 18, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr Peter Metrakos</name_title>
    <organization>MUHC</organization>
  </responsible_party>
  <keyword>Liver</keyword>
  <keyword>transplant</keyword>
  <keyword>albumin</keyword>
  <keyword>outcome</keyword>
  <keyword>Liver transplant recipients canadian transplant status 1 or 2</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

